Clinics and Research in Hepatology and Gastroenterology

Article	Citations
Epidemiology of Cholangiocarcinoma; United States Incidence and Mortality Trends	53
Epidemiology of hepatitis C virus infection	50
Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy	45
Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea	43
The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis	40
Covid-19 in liver transplant recipients: the French SOT COVID registry	40
Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study	39
Effect of liraglutide therapy on serum fetuin A in patients with type 2 diabetes and non-alcoholic fatty liver disease	38
Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?	35
Uncommon presentation of COVID-19: Gastrointestinal bleeding	30
HCV virology and diagnosis	28
Diarrhea: An underestimated symptom in Coronavirus disease 2019	25
Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study	25
A case of COVID-19 patient with the diarrhea as initial symptom and literature review	23
The occurrence of diarrhea in COVID-19 patients	21
Tumor educated platelets, a promising source for early detection of hepatocellular carcinoma: Liquid biopsy an alternative approach to tissue biopsy	21
TIPS for management of portal-hypertension-related complications in patients with cirrhosis	21
Autoimmune hepatitis developing after COVID 19 vaccine: Presumed guilty?	20
LncRNA-SNHG7/miR-29b/DNMT3A axis affects activation, autophagy and proliferation of hepatic stellate cells in liver fibrosis	19
Larazotide acetate for treatment of celiac disease: A systematic review and meta-analysis of randomized controlled trials	19
Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis	19
Efficacy and safety of obeticholic acid in liver disease—A systematic review and meta-analysis	19
Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer	19
Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study	19
Active vitamin D impedes the progression of non-alcoholic fatty liver disease by inhibiting cell senescence in a rat model	18

Microbiome and pancreatic ductal adenocarcinoma	18
Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: Results of a French cohort	18
Severe immune-related hepatitis induced by immune checkpoint inhibitors: Clinical features and management proposal	18
Acute liver failure requiring transplantation caused by ulipristal acetate	18
Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: The impact of uric acid	17
Hepatitis B virus American genotypes: Pathogenic variants ?	17
Homeostatic regulation of food intake	17
Sinusoidal obstruction syndrome	17
A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma	17
Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI)	17
Self-limited gastrointestinal bleeding in COVID-19	16
An increase in prostate cancer diagnosis during inflammatory bowel disease: A systematic review and meta-analysis	16
Statins use and the prognosis of colorectal cancer: a meta-analysis	16
PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinoma	15
Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction	15
MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer	15
Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target	15
Neutrophil extracellular traps induced by pro-inflammatory cytokines enhance procoagulant activity in NASH patients	15
Prospective evaluation of third-generation small bowel capsule endoscopy videos by independent readers demonstrates poor reproducibility of cleanliness classifications	14
Factors associated with non adherence to a gluten free diet in adult with celiac disease: A survey assessed by BIAGI score	14
Effect of novel glucose lowering agents on non-alcoholic fatty liver disease: A systematic review and meta-analysis	14
Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis	14
Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53	14
Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient	13
NAFLD: genetics and its clinical implications	13
Interleukin 22 is related to development and poor prognosis of hepatocellular carcinoma	13
Gastrointestinal, hepatic and pancreatic manifestations of COVID-19 in children	13
Acute liver failure due to DGUOK deficiency–is liver transplantation justified?	13
Prevalence and clinical features of hepatitis E virus infection in pregnant women: A large cohort study in Inner Mongolia, China	12
Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus	12
Inhibition of β-glucosidase overcomes gastric cancer chemoresistance through inducing lysosomal dysfunction	12
The safety and efficacy of anti-PD-1/anti-PD-L1 antibody therapy in the treatment of previously treated, advanced gastric or gastro-oesophageal junction cancer: A meta-analysis of prospective clinical	12
MicroRNA-126-5p suppresses cell proliferation, invasion and migration by targeting EGFR in liver cancer	12
Clinicopathological features, risk of lymph node metastasis and survival outcome of synchronous multiple early gastric cancer	12
The effect of reminiscence therapy-involved care on anxiety, depression, life quality and survival in colorectal cancer patients	12
The mTORC1/AMPK pathway plays a role in the beneficial effects of semaglutide (GLP-1 receptor agonist) on the liver of obese mice	12
Impact of the first Covid-19 outbreak on liver transplantation activity in France: A snapshot	12
Differentiation of solid-pseudopapillary tumors of the pancreas from pancreatic neuroendocrine tumors by using endoscopic ultrasound	12
Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study	12
Risk factors for concomitant infectious pancreatic necrosis in patients with severe acute pancreatitis: A systematic review and meta-analysis	12
The gut microbiome as a target for adjuvant therapy in insomnia disorder	11
LncRNA SLC16A1-AS1 is upregulated in hepatocellular carcinoma and predicts poor survival	11
Vitamin D deficiency negatively affects both the intestinal epithelial integrity and bone metabolism in children with Celiac disease	11
COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms	11
Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy	11
Prevalence of gallstone in Mainland China: A meta-analysis of cross-sectional studies	11
A guide for assessing the clinical relevance of findings in small bowel capsule endoscopy: analysis of 8064 answers of international experts to an illustrated script questionnaire	11
The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase	11
Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review	11
Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study	11

“Health status of children with chronic liver disease during the SARS-CoV-2 outbreak: results from a multicentre study”	11
World Gastroenterology Organisation classification and a new type-based prognostic model for hepatitis B virus-related acute-on-chronic liver failure	11
Effectiveness and safety of biologics in pediatric inflammatory bowel disease: Real-life data from the Sicilian Network	11
Cytochrome P450 2E1 should not be neglected for acetaminophen-induced liver injury in metabolic diseases with altered insulin levels or glucose homeostasis	11
Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma	10
Adjuvanted recombinant HBV vaccine (HBV-AS04) is effective over extended follow-up in dialysis population. An open-label non randomized trial	10
Impact of sarcopenia on clinical outcomes of patients undergoing simultaneous liver and kidney transplantation: a cohort study	10
Quality criteria for the measurement of liver stiffness	10
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study	10
The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers	10
Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?	10
The longitudinal changes of anxiety and depression, their related risk factors and prognostic value in colorectal cancer survivors: a 36-month follow-up study	10
Treatment of hepatitis C virus infection	10
Vaccination in adult liver transplantation candidates and recipients	10
The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study	10
Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort study	10
Refractory celiac disease and COVID-19 outbreak: Findings from a high incidence scenario in Northern Italy	10
Expectations of IBS patients concerning disease and healthcare providers: Results of a prospective survey among members of a French patients’ association	10
Prognosis of patients undergoing salvage TIPS is still poor in the preemptive TIPS era	10
Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials	10
Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients	10
Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic	10
Epstein-Barr virus-negative inflammatory pseudotumor-like variant of follicular dendritic cell sarcoma of the liver: A case report and literature review	10
Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyo	9
Budd-Chiari syndrome	9
Drastic decrease of urgent endoscopies outside regular working hours during the Covid-19 pandemic in the paris area	9
Global burden of non-alcoholic fatty liver disease in 204 countries and territories from 1990 to 2019	9
Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19	9
Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients	9
Long noncoding RNA PVT1 promotes tumour progression via the miR-128/ZEB1 axis and predicts poor prognosis in esophageal cancer	9
Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study	9
Drug induced liver injury and vascular liver disease	9
Congenital portosystemic shunts	9
Telemedicine in the COVID-19 era for Liver Transplant Recipients: an Italian lockdown area experience	9
Clinical interpretation of PRSS1 variants in patients with pancreatitis	9
Optimization of the transition process of youth with liver disease in adulthood: A position paper from FILFOIE, the French network for paediatric and adult rare liver diseases	9
Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study	9
Effect of N-acetylcysteine on remission maintenance in patients with ulcerative colitis: A randomized, double-blind controlled clinical trial	9
Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease	8
Myosteatosis in nonalcoholic fatty liver disease: An exploratory study	8
Long non-coding RNA 01559 mediates the malignant phenotypes of hepatocellular carcinoma cells through targeting miR-511	8
Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survi	8
Adverse events after biliary sphincterotomy: Does the electric current mode make a difference? A systematic review and meta-analysis of randomized controlled trials	8
Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease	8
Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease	8
The MBOAT7 rs641738 variant is associated with an improved outcome in primary sclerosing cholangitis	8
MSI colorectal cancer, all you need to know	8
A systemic mechanism of increased transendothelial migration of leukocytes through the blood-brain barrier in hepatic encephalopathy	8
Regulatory mechanisms of the bile salt export pump (BSEP/ABCB11) and its role in related diseases	8
The type of KRAS mutation drives PI3Kα/γ signalling dependency: Implication for the choice of targeted therapy in pancreatic adenocarcinoma patients	8
Reasons for chemotherapy discontinuation and end-of-life in patients with gastrointestinal cancer: A multicenter prospective AGEO study	8
PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles’ heel?	8
Higher tumor protein kinase D1 correlates with increased tumor size, BCLC stage, CA199 level, AFP level and worse overall survival in hepatocellular carcinoma patients	8
Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease	8
Circular RNA circAFF2 accelerates gastric cancer development by activating miR-6894-5p and regulating ANTXR 1 expression	8
Atypical presentations of coronavirus disease 2019 in a patient with acute obstructive suppurative cholangitis	8
Present and future management of viral hepatitis B and C in children	8
Concurrence of HBV infection and non-alcoholic fatty liver disease is associated with higher prevalence of chronic kidney disease	8
Metabolic syndrome and colorectal adenoma risk: A systematic review and meta‑analysis	8
Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis	8
Non-small-bowel lesions identification by capsule endoscopy: A single centre retrospective study	8
Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners	8
Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery	8
Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19	8
Acute liver failure and HELLP syndrome: A clinical case and literature review	8
Comparison of DEB-TACE and cTACE for the initial treatment of unresectable hepatocellular carcinoma beyond up-to-seven criteria: A single-center propensity score matching analysis	7
Inflammatory bowel disease symptoms at the time of anal fistula lead to the diagnosis of Crohn's disease	7
Colon ischemia: A comprehensive review	7
Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patie	7
Evolution of diagnostic criteria for acute kidney injury in patients with decompensated cirrhosis: A prospective study in a tertiary university hospital	7
Is it time for global adoption of endoscopic retrograde appendicitis therapy of acute appendicitis?	7
Immune checkpoint inhibitor induced colitis: A nationwide population-based study	7
Duration from the first pale stool to portoenterostomy is prognostic in biliary atresia. Comparison with age at portoenterostomy	7
Surgical management of oligometastatic disease in gastric cancer	7
Cellular communication network factor 1 (CCN1) knockdown exerts a protective effect for hepatic ischemia/reperfusion injury by deactivating the MEK/ERK pathway	7
B-cell compartment abnormalities are associated with ACLF and mortality in patients with liver cirrhosis	7
Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis	7
Anastomotic bilio-biliary stricture after adult liver transplantation: A retrospective study over 20 years in a single center	7
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma	7
Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis	7

Methylprednisolone-related liver injury: A descriptive study using the French pharmacovigilance database	7
Efficacy and safety of islet autotransplantation after total pancreatectomy in chronic pancreatitis: A systematic review and meta-analysis including 17 studies	7
Trimetazidine alone or in combination with gemcitabine and/or abraxane decreased cell viability, migration and ATP levels and induced apoptosis of human pancreatic cells	7
Acute liver and cardiac failure in multisystem inflammatory syndrome in adults after COVID-19	7
Characteristics and outcome of primary Budd-Chiari syndrome due to Behçet's syndrome	7
Non-invasive diagnosis and follow-up of rare genetic liver diseases	7
Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review	7
Ischemic cholangiopathy: An update	7
Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy	7
Prevalence and prognosis of microsatellite instability in oesogastric adenocarcinoma, NORDICAP 16-01	7
Long non-coding RNA ANRIL serves as a potential marker of disease risk, inflammation, and disease activity of pediatric inflammatory bowel disease	7
The research progress of Wnt/β-catenin signaling pathway in colorectal cancer	7
CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis	7
A new model based on gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts prognostic outcome after curative resection of solitary hepatocellular carcinoma	7
TACE plus PD-1 inhibitor (Camrelizumab) treatment for bridging to tumor resection in HCC: Case reports	7
Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: An NHANES analysis	7
Chronic hepatitis E in an immunocompetent patient	7
LUM is the hub gene of advanced fibrosis in nonalcoholic fatty liver disease patients	7
Italian migrants study: An HCV and HBV micro-elimination pilot project	7
Portal hypertension, advanced hepatocellular carcinoma and therapy by atezolizumab-bevacizumab: A “menage à trois” !	7
Endoscopic resection versus esophagectomy for patients with small-sized T1N0 esophageal cancer: A propensity-matched study	7
Eosinophilic colitis in adults	6
Transient elastography for assessment of fibrosis and steatosis of liver grafts from brain-death donors	6
Gemcitabine-facilitated modulation of the tumor microenvironment and PD-1/PD-L1 blockade generate a synergistic antitumor effect in a murine hepatocellular carcinoma model	6
Non-coding RNAs as biomarkers for hepatocellular carcinoma—A systematic review	6
Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality	6
Covid19 vaccination-associated portal vein thrombosis—An interdisciplinary clinical challenge	6
The endless history or search for the true role of alloantibodies in liver transplantation	6
Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials	6
Pulmonary infection after hepatic resection: Associated factors and impact on outcomes	6
Liver transplantation for critically ill cirrhotic patients: Results from the French transplant registry	6
Biallelic mutations in DCDC2 cause neonatal sclerosing cholangitis in a Chinese family	6
Frailty, sarcopenia and mortality in cirrhosis: what is the best assessment, how to interpret the data correctly and what interventions are possible?	6
Transient elastography through controlled attenuated parameter assisting the stratification of cardiovascular disease risk in NAFLD patients	6
Combination of quantitative hepatitis B core antibody (qHBcAb) and aspartate aminotransferase (AST) can accurately diagnose immune tolerance of chronic hepatitis B virus infection based on liver biops	6
Metabolic-associated fatty liver disease and the risk of cardiovascular disease	6
Partial major hepatectomy with cyst fenestration for polycystic liver disease: Indications, short and long-term outcomes	6
Experience with the use of a hemostatic powder in 152 patients undergoing urgent endoscopy for gastrointestinal bleeding	6
Influence of aspirin use on clinical outcomes of patients with hepatocellular carcinoma: a meta-analysis	6
Thiopurine hepatotoxicity can mimic intrahepatic cholestasis of pregnancy	6
Is survival for hepatocellular carcinoma increasing? A population-based study on survival of hepatocellular carcinoma patients in the 1990s and 2000s	6
Advances in cell death - related signaling pathways in acute-on-chronic liver failure	6
Excessive anxiety in IBD patients is unnecessary for COVID-19	6
Oral ibuprofen promoted cholestatic liver disease in very low birth weight infants with patent ductus arteriosus	6
Association of the pretreatment lung immune prognostic index with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors	6
Long-term results of pediatric liver transplantation for autoimmune liver disease	6
Cytomegalovirus in pediatric inflammatory bowel disease patients with acute severe colitis	6
Influence of everolimus-based treatment on circulating regulatory T cells after liver transplantation: Comparative study with tacrolimus-based therapy	6
TIPS for patients with early HCC: A bridge to liver transplantation	6
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response	6
The clinical effect of early enteral nutrition in liver-transplanted patients: a systematic review and meta-analysis	6
Pancreatic cancer and oligonucleotide therapy: Exploring novel therapeutic options and targeting chemoresistance	5
Comparative efficacy of diabetes medications on liver enzymes and fat fraction in patients with nonalcoholic fatty liver disease: A network meta-analysis,,	5
Association of shear-wave elastography with clinical outcomes post-liver transplantation	5
Angioedema with severe acute abdominal pain: Think of hereditary angioedema	5
Positive histologic margins is a risk factor of recurrence after ileocaecal resection in Crohn’s disease	5
Red flags for the diagnosis of autoimmune gastritis	5
Peripheral eosinophilia and hypoalbuminemia are associated with a higher biopsy diagnostic yield for eosinophilic gastroenteritis	5
The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study	5
Management of portal cavernoma-associated cholangiopathy: Single-centre experience	5
Transarterial chemoembolization (TACE) plus apatinib vs. TACE alone for hepatocellular carcinoma	5
Real life experience of mycophenolate mofetil monotherapy in liver transplant patients	5
Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma	5
Peroxisome-related genes in hepatocellular carcinoma correlated with tumor metabolism and overall survival	5
Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal	5
Comparison of sodium-glucose cotransporter-2 inhibitors and thiazolidinediones for management of non-alcoholic fatty liver disease: A systematic review and meta-analysis	5
TSHZ3 functions as a tumor suppressor by DNA methylation in colorectal cancer	5
Liver health literacy and social stigma of liver disease: A general population e-survey	5
Inhibition of USP11 sensitizes gastric cancer to chemotherapy via suppressing RhoA and Ras-mediated signaling pathways	5
The role of miRNA125b in the progression of hepatocellular carcinoma	5
The clinical value of kinesin superfamily protein 2A in hepatocellular carcinoma	5
Elevated LINC01232 is associated with poor prognosis and HBV infection in hepatocellular carcinoma patients and contributes to tumor progression in vitro	5
A novel mutation of PCSK1 responsible for PC1/3 deficiency in two siblings	5
Long-term outcome of patients with difficult-to-treat autoimmune hepatitis receiving mycophenolate mofetil	5
Comparison of Interferon-α-based therapy and nucleos(t)ide analogs in preventing adverse outcomes in patients with chronic hepatitis B	5
Adenosquamous carcinoma of the pancreas	5
A predictive score of inadequate bowel preparation based on a self-administered questionnaire: PREPA-CO	5
Clinicopathological assessment of steatohepatitic hepatocellular carcinoma	5
Sodium taurocholate co-transporting polypeptide deficiency	5
Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study	5
Gender differences in liver fibrosis among patients younger than 50 years: A retrospective cohort study	5
HLA matching and rabbit antithymocyte globulin as induction therapy to avoid multiple forms of rejection after a third liver transplantation	5
Hereditary diffuse gastric cancer (HDGC). An overview	5
Adult diffuse hepatic hemangiomatosis: A case report and review of the literature	5
Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity?	5
Different clinicopathologic features and prognostic significance of signet ring cell histology in early and locally advanced gastric cancer patients	5
Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators	5
A twelve-year study of the prevalence, risk factors and characteristics of interval colorectal cancers after negative colonoscopy	5
Non-invasive diagnosis and follow-up of autoimmune hepatitis	5
Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil	5